Global Osseointegration Implants Market, by Product Type (Dental Implants, Knee Implants, Hip Implants, Spinal Implants and Others), by Material Type (Titanium Implants, Zirconia Implants, Stainless Steel Implants, Ceramic Implants, and Others), by End User (Hospitals, Ambulatory Centers, Dental and Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 7,558.90 Million in 2022 and is expected to exhibit a CAGR of 6.3% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Key players in osseointegration implants market are launching innovative products to generate a reasonable amount of share in the market. For instance, in June 2017, DePuy Synthes Companies launched Fenestrated Screw Systems- VIPER and EXPEDIUM in the U.S. market. These products would re-establish the correct posture of the spinal column in patients with advanced stage spinal tumors.
Global Osseointegration Implants Market– Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
However, the COVID-19 pandemic had a negative impact on the global osseointegration implants market, owing to decrease in supply of Osseointegration Implants. For instance, in February 2021, according to the data published by the National Center for Biotechnology Information, pandemics cause chaotic situations in supply chains (SC) around the globe, which can lead towards survivability challenges. The distribution chain for medical devices was hampered due to the manufacturers and distributors engaged in supply of the essential commodities and drugs used in treatment of coronavirus. The lockdown all over the world resisted the import and export of raw material for manufacturing the implants which decreased the supply of Osseointegration Implants.
Global Osseointegration Implants Market: Key Developments
In January 2022, NuVasive, Inc., medical devices company, announced that the company received the U.S. Food and Drug Administration (FDA) 510(k) clearance for expanded indications of use for Attrax Putty with its comprehensive thoracolumbar interbody portfolio for spine surgery. Attrax Putty is the first synthetic biologic to receive indications for use in interbody fusions of the thoracolumbar spine. The NuVasive Attrax Putty is a synthetic, bioactive and osteoconductive bone void filler designed to drive bone fusion.
Browse 27 Market Data Tables and 24 Figures spread through 153 Pages and in-depth TOC on “Global Osseointegration Implants Market”- Forecast to 2030, Global Osseointegration Implants Market, by Product Type (Dental Implants, Knee Implants, Hip Implants, Spinal Implants and Others), by Material Type (Titanium Implants, Zirconia Implants, Stainless Steel Implants, Ceramic Implants, and Others), by End User (Hospitals, Ambulatory Centers, Dental and Orthopedic Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/osseointegration-implants-market-2384
Key Takeaways of the Global Osseointegration Implants Market:
- The global osseointegration implants market is expected to exhibit a CAGR of 6.3% during the forecast period due to the increasing launches of new products by the key players in the market. For instance, in January 2021, Nobel Biocare, a company that manufactures dental implants and CAD/CAM-based individualized prosthetics invites dental professionals to join the Mucointegration era with the launch of the Xeal and TiUltra surfaces in the U.S. New Xeal abutments feature next-generation surface chemistry designed to promote soft-tissue attachment. In a clinical study with a two-year follow-up, the Xeal surface demonstrated a significant increase in soft-tissue height compared to machined abutment surfaces. The TiUltra surface promotes early osseointegration. The surface was developed to further promote early osseointegration and support bone stability. With an ultra-hydrophilic, multi-zoned implant surface, the TiUltra surface is taking anodization technology one step further.
- Among material type, ceramic implants segment is projected to have the highest CAGR during the forecast period, owing to its biocompatibility and aesthetic appearance.
- Among regions, North America is estimated to account for the largest market share in the global osseointegration implants market over the forecast period, owing to the increasing product launches in the U.S. For instance, in October 2021, NuVasive, Inc., medical devices company launched the Cohere TLIF-O implant and upcoming launch of the Cohere TLIF-A implant planned for later in the fourth quarter. With these additions to its Advanced Materials Scienc (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.
- Major players operating in the global osseointegration implants market include DENTSPLY Sirona, Danaher Corporation, Camlog, Osstem Implant, Medtronic, Stryker Corporation, Zimmer Biomet Holdings, Smith and Nephew Plc., Straumann AG Group, Integrum SE, ConMed Corporation, Southern Implants.
